Haytham Tawfik

42PUBLICATIONS
84CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targetsBiomolecular modelling and designBiologically active moleculesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Aug 10, 2026
Targeting CDK-2 With Novel Indole-Pyrazole Hybrids: Discovery of Potent Anticancer Agents Supported by Mechanistic and In Silico Studies.

|Jun 22, 2026
Identification of Sulfonamide-Based Thiazolidine-2,4-Dione Derivatives as VEGFR-2 and Tumor-Associated hCA IX Inhibitors With Hypoxia-Targeted Anti-Colorectal Cancer Activity.

|May 28, 2026
Molecular Boomerangs Against Cancer: Design, Synthesis, Biological Evaluation, and In Silico Study of Novel Dual PARP-1/EGFR Inhibitors.

|May 13, 2026
Development of novel chalcone-based quinazoline derivatives as dual VEGFR-2 and EGFR inhibitors.

|Apr 24, 2026
Pyrazole-triazole hybrids as kinase-triad inhibitors: a triple-target strategy for synergistic anticancer therapy.

|Mar 30, 2026
Synthesis and Biological Evaluation of Imidazopyridine-Isatin Hybrids as Inhibitors of Leishmania major Growth.

Mahmoud A El Hassab, Wagdy M Eldehna, Zainab M Elsayed

Pageof 7

Frequent Collaborators

23 joint publications

Wagdy M Eldehna

14 joint publications

Moataz Shaldam

11 joint publications

Claudiu T Supuran

7 joint publications

Mohamed S Nafie